Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic

Covid19 Clinical Trial

Official title:

Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic: Retrospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04480060
• Other study ID #: KSSEAH--EDCC
• Status: Completed
• Start date: March 10, 2020
• Est. completion date: July 14, 2020

Study information

• Verified date: July 2020
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Emergency departments also carried out an important part of the fight against pandemics in our country/Turkey. The emergency department including an intensive care unit is very few in this country/Turkey and the only hospital, which has an Emergency Intensive Care Unit (EICU) in Istanbul, is the study center. Therefore, this retrospective study aimed to provide useful information about how an effective EICU should be, especially how to use them during pandemic periods.

Description:

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Emergency departments also carried out an important part of the fight against pandemics in our country/Turkey. The emergency department including an intensive care unit is very few in this country/Turkey and the only hospital, which has an Emergency Intensive Care Unit (EICU) in Istanbul, is the study center. Throughout the pandemic, many patients, including COVID-19 patients, were successfully followed up and discharged from EICU. With this study, the investigators expect to show the role of EICU during the pandemic. In addition, it will be seen that whether the patients, who are waiting for hospitalization or waiting for referral, are admitted to EICU faster and their treatments will be started promptly. Therefore, this retrospective study aimed to provide useful information about how an effective EICU should be, especially how to use them during pandemic periods.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100000
• Est. completion date: July 14, 2020
• Est. primary completion date: June 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• All patients who followed up in emergency department ICU with the diagnosis of COVID-19

• Accepted to participate with an informed consent

Exclusion Criteria:

• Patients under the age of 18 or more than 50 years

• declined to participate

• deaths caused by other than COVID-19

Related Conditions & MeSH terms

• Covid19
• Emergencies

Intervention

Diagnostic Test:
• COVID-19 diagnostic PCR
Nasopharyngeal swab samples will be analyzed by PCR for COVID-19 DNA existence.

Locations

Country	Name	City	State
Turkey	Seda Yilmaz Semerci	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality of the COVID-19 patients	Mortality of the COVID-19 patients who followed up by emergency department ICU	3 months